Fosamax news from FiercePharma
News
Safety questions on Fosamax, Actos, et al.
It must be tough for pharma execs to open a newspaper these days. If reporters aren't going on about Read more...
Wyeth makes its own Protonix copy
Wyeth decided to beat the copycats to the punch. The drug maker will launch its own generic version of the blockbuster heartburn med Protonix, more than two years ahead of its patent expiration. Read more...
Drug name psychology, or the power of Z
You know about those product-naming experts who charge hundreds of thousands for just the right combinations of vowels and consonants. Well, the Associated Press today draws the curtain aside to Read more...
SPOTLIGHT: Doubt cast on Fosamax link to jaw decay
A new study by a Harvard dental professor may cast doubt on some claims that Merck's osteoporosis drug Fosamax caused some patients' Read more...
Merck joins Fosamax copycats
Merck won't be outdone on Fosamax. The company has struck a deal with an unidentified generics supplier for an authorized, copycat form of the osteoporosis drug. The Merck-blessed generic could go on Read more...
Analysts get bullish on generics makers
The flip side of Big Pharma's angst over generic competition is growing exuberance about generics makers. Read more...
Merck expects $1.8B hit on Fosamax
We all knew that losing patent protection on Fosamax would cut into Merck's sales next year. We just didn't know how much. Now we do, or at least we know Merck's best estimate: about $1.8 billion. Read more...
ALSO NOTED: Amgen drug fails breast cancer trial; Patients want class status in Fosamax suit;
> Amgen's anemia drug Aranesp failed to shrink breast tumors in an early-stage trial of the Read more...
Pharma growth sinking to historic low
Here's statistical confirmation of the gloom-and-doom facing Big Pharma. Worldwide sales growth will slow next year to around 5 Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends